| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
233 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
1 |
| Cash Flow (TTM) (Millions $) |
-3 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Owc Pharmaceutical Research Corp. is a biopharmaceutical company that focuses on the development of medical cannabis-based treatments for a variety of medical conditions and disorders. The company utilizes its proprietary technology to develop cannabis-based products that are standardized, safe, and effective.
Owc Pharmaceutical Research Corp. conducts extensive research and clinical trials to prove the efficacy of its products and ensure they meet regulatory standards. The company's goal is to harness the therapeutic potential of cannabinoids to improve the quality of life for patients suffering from various ailments, including multiple sclerosis, psoriasis, and inflammatory bowel disease.
In addition to its research and development efforts, Owc Pharmaceutical Research Corp. also works on establishing strategic partnerships with other pharmaceutical companies and healthcare providers to further advance the use of cannabis-based medicines. The company operates in multiple countries, including Israel, the United States, and Canada, where medical cannabis is legal or in the process of being legalized.
Overall, Owc Pharmaceutical Research Corp. is committed to utilizing scientific advancements and innovative technologies to unlock the full potential of medical cannabis and provide effective treatment options for patients worldwide.
|
0.000%